CN103055014B - 一种预防老年痴呆症的银杏叶保健品及其制备方法 - Google Patents
一种预防老年痴呆症的银杏叶保健品及其制备方法 Download PDFInfo
- Publication number
- CN103055014B CN103055014B CN201210586523.XA CN201210586523A CN103055014B CN 103055014 B CN103055014 B CN 103055014B CN 201210586523 A CN201210586523 A CN 201210586523A CN 103055014 B CN103055014 B CN 103055014B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- portions
- folium ginkgo
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000008100 Ginkgo biloba Nutrition 0.000 title claims abstract description 103
- 235000011201 Ginkgo Nutrition 0.000 title claims abstract description 101
- 208000024827 Alzheimer disease Diseases 0.000 title claims abstract description 34
- 230000036541 health Effects 0.000 title claims abstract description 34
- 206010039966 Senile dementia Diseases 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims description 17
- 241000218628 Ginkgo Species 0.000 title claims 17
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 88
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 235000011438 Albizia odoratissima Nutrition 0.000 claims abstract description 7
- 230000002829 reductive effect Effects 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 81
- 210000000582 semen Anatomy 0.000 claims description 44
- 238000001914 filtration Methods 0.000 claims description 39
- 239000000047 product Substances 0.000 claims description 29
- 239000000284 extract Substances 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 14
- 241000756943 Codonopsis Species 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 13
- 230000002265 prevention Effects 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 10
- 238000001556 precipitation Methods 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- 241000208966 Polygala Species 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000002674 ointment Substances 0.000 claims description 7
- 241000220433 Albizia Species 0.000 claims description 6
- 241000545442 Radix Species 0.000 claims description 6
- 230000003179 granulation Effects 0.000 claims description 6
- 238000005469 granulation Methods 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 238000002481 ethanol extraction Methods 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 238000000108 ultra-filtration Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 241001055174 Asterinides folium Species 0.000 claims description 2
- 239000002893 slag Substances 0.000 claims description 2
- 239000012567 medical material Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 50
- 210000004369 blood Anatomy 0.000 abstract description 49
- 239000003814 drug Substances 0.000 abstract description 31
- 230000006870 function Effects 0.000 abstract description 25
- 239000004615 ingredient Substances 0.000 abstract description 8
- 210000004958 brain cell Anatomy 0.000 abstract description 7
- 210000001519 tissue Anatomy 0.000 abstract description 6
- 230000001976 improved effect Effects 0.000 abstract description 4
- 231100000419 toxicity Toxicity 0.000 abstract description 4
- 230000001988 toxicity Effects 0.000 abstract description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 3
- 229910052760 oxygen Inorganic materials 0.000 abstract description 3
- 239000001301 oxygen Substances 0.000 abstract description 3
- 230000000717 retained effect Effects 0.000 abstract description 3
- 230000003925 brain function Effects 0.000 abstract description 2
- 240000000559 Albizia odoratissima Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000167854 Bourreria succulenta Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 240000007049 Juglans regia Species 0.000 abstract 1
- 235000009496 Juglans regia Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241001080798 Polygala tenuifolia Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000612118 Samolus valerandi Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 210000005013 brain tissue Anatomy 0.000 abstract 1
- 235000019693 cherries Nutrition 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 235000020234 walnut Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 47
- 239000000243 solution Substances 0.000 description 28
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 22
- 210000003734 kidney Anatomy 0.000 description 22
- 210000002216 heart Anatomy 0.000 description 21
- 201000010099 disease Diseases 0.000 description 20
- YXHVCZZLWZYHSA-FPLPWBNLSA-N Ginkgoic acid Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-FPLPWBNLSA-N 0.000 description 18
- 241001465754 Metazoa Species 0.000 description 16
- 230000007812 deficiency Effects 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 14
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 13
- 229940079593 drug Drugs 0.000 description 13
- 206010022437 insomnia Diseases 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 11
- 206010033557 Palpitations Diseases 0.000 description 11
- 210000004204 blood vessel Anatomy 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 208000002173 dizziness Diseases 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 208000009205 Tinnitus Diseases 0.000 description 9
- 230000001476 alcoholic effect Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 231100000886 tinnitus Toxicity 0.000 description 9
- 206010008190 Cerebrovascular accident Diseases 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 208000006011 Stroke Diseases 0.000 description 8
- 208000031971 Yin Deficiency Diseases 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 230000001914 calming effect Effects 0.000 description 8
- 230000006378 damage Effects 0.000 description 8
- 210000003414 extremity Anatomy 0.000 description 8
- 230000007774 longterm Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 7
- 239000009636 Huang Qi Substances 0.000 description 7
- 238000005728 strengthening Methods 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 230000002936 tranquilizing effect Effects 0.000 description 7
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 6
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000004821 distillation Methods 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 210000004209 hair Anatomy 0.000 description 6
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 6
- 229960004844 lovastatin Drugs 0.000 description 6
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 210000000578 peripheral nerve Anatomy 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 206010033799 Paralysis Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 208000001431 Psychomotor Agitation Diseases 0.000 description 5
- 206010038743 Restlessness Diseases 0.000 description 5
- 208000033809 Suppuration Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 208000026106 cerebrovascular disease Diseases 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 231100000862 numbness Toxicity 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 4
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- -1 flavone compound Chemical class 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000006386 memory function Effects 0.000 description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 206010029410 night sweats Diseases 0.000 description 4
- 230000036565 night sweats Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 4
- 229960002646 scopolamine Drugs 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 206010012289 Dementia Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 3
- 240000005373 Panax quinquefolius Species 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 230000000916 dilatatory effect Effects 0.000 description 3
- 230000009189 diving Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 238000009533 lab test Methods 0.000 description 3
- 150000002596 lactones Chemical class 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 235000011649 selenium Nutrition 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000026139 Memory disease Diseases 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 206010047531 Visual acuity reduced Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000008828 contractile function Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 238000009738 saturating Methods 0.000 description 2
- JVXZRQGOGOXCEC-UHFFFAOYSA-N scutellarein Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(O)=C(O)C=C2O1 JVXZRQGOGOXCEC-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003848 thrombocyte activating factor antagonist Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 235000016804 zinc Nutrition 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- YXHVCZZLWZYHSA-UHFFFAOYSA-N (Z)-6-[8-pentadecenyl]salicylic acid Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-UHFFFAOYSA-N 0.000 description 1
- 102100027831 14-3-3 protein theta Human genes 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 208000006888 Agnosia Diseases 0.000 description 1
- 241001047040 Agnosia Species 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- 206010002942 Apathy Diseases 0.000 description 1
- 206010003062 Apraxia Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008027 Cerebellar atrophy Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- HKLUUHOGFLPVLP-UHFFFAOYSA-N Datin Natural products C=1C(OC)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=CC=C1O HKLUUHOGFLPVLP-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000086550 Dinosauria Species 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010049669 Dyscalculia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- SQGLUEWZRKIEGS-UHFFFAOYSA-N Ginkgetin Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 SQGLUEWZRKIEGS-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 241000190019 Guaiacum Species 0.000 description 1
- 235000004440 Guaiacum sanctum Nutrition 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010034719 Personality change Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000008630 Sialorrhea Diseases 0.000 description 1
- 206010041243 Social avoidant behaviour Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- UNWAHVGSROASNT-HXNJGWPRSA-N amarolide Chemical compound C[C@H]1C(=O)[C@@H](O)[C@@H]2[C@@]3(C)C(=O)[C@@H](O)C[C@@H](C)[C@@H]3C[C@@H]3[C@@]2(C)[C@H]1CC(=O)O3 UNWAHVGSROASNT-HXNJGWPRSA-N 0.000 description 1
- UNWAHVGSROASNT-UHFFFAOYSA-N amarolide Natural products CC1C(=O)C(O)C2C3(C)C(=O)C(O)CC(C)C3CC3C2(C)C1CC(=O)O3 UNWAHVGSROASNT-UHFFFAOYSA-N 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- AIFCFBUSLAEIBR-UHFFFAOYSA-N ginkgetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(OC)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 AIFCFBUSLAEIBR-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000007489 histopathology method Methods 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000008929 jingui shenqi Substances 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000008965 mitochondrial swelling Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 210000002682 neurofibrillary tangle Anatomy 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 1
- 229910052683 pyrite Inorganic materials 0.000 description 1
- 239000011028 pyrite Substances 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- HSTCACQRSLZQHZ-UHFFFAOYSA-N shinjulactone H Natural products CC1CC(O)C(=O)C2(C)C1CC3OC(=O)CC4C(C)C(O)C(=O)C2C34C HSTCACQRSLZQHZ-UHFFFAOYSA-N 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210586523.XA CN103055014B (zh) | 2012-12-31 | 2012-12-31 | 一种预防老年痴呆症的银杏叶保健品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210586523.XA CN103055014B (zh) | 2012-12-31 | 2012-12-31 | 一种预防老年痴呆症的银杏叶保健品及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103055014A CN103055014A (zh) | 2013-04-24 |
CN103055014B true CN103055014B (zh) | 2014-09-17 |
Family
ID=48098109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210586523.XA Expired - Fee Related CN103055014B (zh) | 2012-12-31 | 2012-12-31 | 一种预防老年痴呆症的银杏叶保健品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103055014B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103315231B (zh) * | 2013-07-17 | 2014-11-05 | 江苏绿茵生物科技有限公司 | 一种预防老年痴呆的营养麦片及其制备方法 |
CN104000202A (zh) * | 2014-06-17 | 2014-08-27 | 史克勇 | 含有远志的保健食品 |
CN106038986A (zh) * | 2016-06-09 | 2016-10-26 | 童松 | 一种健脑补肾酒 |
CN108464192A (zh) * | 2018-06-19 | 2018-08-31 | 贵州省贵福菌业发展有限公司 | 一种油茶菇菌种活化培养基 |
CN109875040A (zh) * | 2019-04-17 | 2019-06-14 | 安徽金源药业有限公司 | 一种缓解体力疲劳、美容养颜虫草人参阿胶片及制备方法 |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1072860A (zh) * | 1992-12-11 | 1993-06-09 | 唐山市龙山制药厂 | 抗脑衰胶囊的配方及制备工艺 |
CN1178119A (zh) * | 1997-10-13 | 1998-04-08 | 首都医科大学宣武医院 | 一种治疗老年痴呆症的中药制剂 |
CN1336217A (zh) * | 2001-07-31 | 2002-02-20 | 李国荣 | 一种治疗精神发育迟缓及老年期痴呆的中药制剂 |
CN1562216A (zh) * | 2004-04-07 | 2005-01-12 | 北京奇源益德药物研究所 | 一种治疗心脑血管疾病的中药制剂及其制备方法 |
CN1634243A (zh) * | 2004-09-24 | 2005-07-06 | 贵阳云岩西创药物科技开发有限公司 | 治疗心脑血管疾病的复方黄芪制剂及其制备方法 |
CN1657084A (zh) * | 2004-09-06 | 2005-08-24 | 青岛国风药业股份有限公司 | 一种治疗血管性痴呆的中药口服制剂 |
CN1872126A (zh) * | 2005-06-02 | 2006-12-06 | 成都迅科医药科技有限责任公司 | 一种治疗老年痴呆的药物组合物 |
CN1965919A (zh) * | 2005-11-15 | 2007-05-23 | 北京奇源益德药物研究所 | 治疗心脑血管疾病的中药制剂及其制备方法和应用 |
CN101084936A (zh) * | 2006-06-08 | 2007-12-12 | 天津天士力之骄药业有限公司 | 银杏叶提取物的制备方法 |
CN101168025A (zh) * | 2007-10-25 | 2008-04-30 | 张占军 | 一种防治老年性痴呆的药物组合物 |
CN101190269A (zh) * | 2006-12-01 | 2008-06-04 | 张作光 | 一组改善认知功能障碍和治疗老年痴呆症的药物组合物 |
CN101229230A (zh) * | 2008-01-23 | 2008-07-30 | 北京梅斐技术开发中心 | 一种治疗老年性痴呆综合症的中药合剂 |
CN101766784A (zh) * | 2008-12-26 | 2010-07-07 | 北京天科仁祥医药科技有限公司 | 一种治疗老年性痴呆的中药颗粒剂 |
CN101879291A (zh) * | 2009-10-30 | 2010-11-10 | 黄师正 | 解郁安神合剂汤(加散)、丸 |
CN102085282A (zh) * | 2010-12-29 | 2011-06-08 | 庞来祥 | 治疗智力低下及老年痴呆的中药组合物及其制法和检测方法 |
CN102233009A (zh) * | 2011-06-21 | 2011-11-09 | 广东药学院 | 一种促进神经再生的中药组合物及其制备方法和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11209274A (ja) * | 1998-01-22 | 1999-08-03 | Bae O-Sung | 疾病治療用喫煙物 |
KR100804480B1 (ko) * | 2006-04-27 | 2008-02-20 | 한국과학기술연구원 | 기억력 증진 조성물 |
US20090155392A1 (en) * | 2007-12-17 | 2009-06-18 | Bret David Nelson | Methods and Systems for Sublingual Guarana Administration |
-
2012
- 2012-12-31 CN CN201210586523.XA patent/CN103055014B/zh not_active Expired - Fee Related
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1072860A (zh) * | 1992-12-11 | 1993-06-09 | 唐山市龙山制药厂 | 抗脑衰胶囊的配方及制备工艺 |
CN1178119A (zh) * | 1997-10-13 | 1998-04-08 | 首都医科大学宣武医院 | 一种治疗老年痴呆症的中药制剂 |
CN1336217A (zh) * | 2001-07-31 | 2002-02-20 | 李国荣 | 一种治疗精神发育迟缓及老年期痴呆的中药制剂 |
CN1562216A (zh) * | 2004-04-07 | 2005-01-12 | 北京奇源益德药物研究所 | 一种治疗心脑血管疾病的中药制剂及其制备方法 |
CN1657084A (zh) * | 2004-09-06 | 2005-08-24 | 青岛国风药业股份有限公司 | 一种治疗血管性痴呆的中药口服制剂 |
CN1634243A (zh) * | 2004-09-24 | 2005-07-06 | 贵阳云岩西创药物科技开发有限公司 | 治疗心脑血管疾病的复方黄芪制剂及其制备方法 |
CN1872126A (zh) * | 2005-06-02 | 2006-12-06 | 成都迅科医药科技有限责任公司 | 一种治疗老年痴呆的药物组合物 |
CN1965919A (zh) * | 2005-11-15 | 2007-05-23 | 北京奇源益德药物研究所 | 治疗心脑血管疾病的中药制剂及其制备方法和应用 |
CN101084936A (zh) * | 2006-06-08 | 2007-12-12 | 天津天士力之骄药业有限公司 | 银杏叶提取物的制备方法 |
CN101190269A (zh) * | 2006-12-01 | 2008-06-04 | 张作光 | 一组改善认知功能障碍和治疗老年痴呆症的药物组合物 |
CN101168025A (zh) * | 2007-10-25 | 2008-04-30 | 张占军 | 一种防治老年性痴呆的药物组合物 |
CN101229230A (zh) * | 2008-01-23 | 2008-07-30 | 北京梅斐技术开发中心 | 一种治疗老年性痴呆综合症的中药合剂 |
CN101766784A (zh) * | 2008-12-26 | 2010-07-07 | 北京天科仁祥医药科技有限公司 | 一种治疗老年性痴呆的中药颗粒剂 |
CN101879291A (zh) * | 2009-10-30 | 2010-11-10 | 黄师正 | 解郁安神合剂汤(加散)、丸 |
CN102085282A (zh) * | 2010-12-29 | 2011-06-08 | 庞来祥 | 治疗智力低下及老年痴呆的中药组合物及其制法和检测方法 |
CN102233009A (zh) * | 2011-06-21 | 2011-11-09 | 广东药学院 | 一种促进神经再生的中药组合物及其制备方法和应用 |
Non-Patent Citations (5)
Title |
---|
JP特开平11-209274A 1999.08.03 |
中西医结合治疗血管性痴呆60例疗效观察;陈莲风;《山西中医》;20070228;第23卷(第1期);第33-34页 * |
李永利等.中医药治疗老年痴呆进展.《疑难病杂志》.2003,第2卷(第3期), * |
陈莲风.中西医结合治疗血管性痴呆60例疗效观察.《山西中医》.2007,第23卷(第1期), |
顾维超.心脾两虚.《中医内科学》.1998,(第1版), * |
Also Published As
Publication number | Publication date |
---|---|
CN103055014A (zh) | 2013-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102988638B (zh) | 一种青钱柳叶降脂降糖保健茶及其制备方法 | |
CN104435775A (zh) | 一种中药保健酒及其制备方法 | |
CN103734424B (zh) | 一种苦荞减肥降脂通便茶及其制备方法 | |
CN101632769B (zh) | 一种调节血糖的中药组合物及其制备方法 | |
CN103055014B (zh) | 一种预防老年痴呆症的银杏叶保健品及其制备方法 | |
CN103041208B (zh) | 一种治疗妇女更年期综合征的中药制剂及其制备方法 | |
CN103055259B (zh) | 一种枸杞叶降脂减肥保健茶及其制备方法 | |
CN103041264B (zh) | 一种防治血管性痴呆葛根补脑益智口服液及其制备方法 | |
CN103041309A (zh) | 一种银杏叶美容口服液及其制备方法 | |
CN103749822A (zh) | 一种女贞子降压降脂保健茶及其制备方法 | |
CN103719493B (zh) | 一种补脑益智的黄精保健茶及其制备方法 | |
CN101628068A (zh) | 一种治疗青少年白发的药物组合及其制备方法 | |
CN105267477A (zh) | 一种清肝明目的丹参叶保健茶及其制备方法 | |
CN104365943A (zh) | 一种降糖降脂的槐角茶及其制备方法 | |
CN104398790A (zh) | 一种防治心悸失眠、神经衰弱的罗布麻叶口服液及其制备方法 | |
CN103735835A (zh) | 一种治疗少白头的中药制剂及其制备方法 | |
CN103223111A (zh) | 一种治疗糖尿病肾病的中药组合物及其制备方法 | |
CN103041070B (zh) | 一种银杏叶降脂降压保健品及其制备方法 | |
CN104472789A (zh) | 一种润肠通便的槐角茶及其制备方法 | |
CN104940844A (zh) | 一种治疗肝火上炎型心悸失眠的中药制剂及其制备方法 | |
CN106177432A (zh) | 一种包含青钱柳叶、桑叶、绿茶和玉竹的保健组合物 | |
CN104474472A (zh) | 具有降三高作用的苦丁茶含片及其生产方法 | |
CN103749819A (zh) | 一种降糖降脂的山茱萸保健茶及其制备方法 | |
CN106215118A (zh) | 抗肿瘤的保健制剂及其制备方法 | |
CN105343593A (zh) | 一种降压降脂的夏枯草保健口服液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Applicant after: Qingdao Huaren Technology Incubator Co., Ltd. Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 (Minmetals building) 11 1101-A Applicant before: Qingdao Huaren Information Technology Development Co., Ltd. |
|
CB03 | Change of inventor or designer information |
Inventor after: Wei Lihong Inventor after: Li Yu Inventor after: Zhou Xiaohua Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: WEI LIHONG LI YU ZHOU XIAOHUA Free format text: CORRECT: APPLICANT; FROM: QINGDAO HUAREN INFORMATION TECHNOLOGY DEVELOPMENT CO., LTD. TO: QINGDAO HUAREN TECHNOLOGY INCUBATOR CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Xu Xuewan Inventor before: Wei Lihong Inventor before: Li Yu Inventor before: Zhou Xiaohua |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160629 Address after: 225300, Jiangsu, Taizhou Province High Street Port Street, Far East Avenue North Patentee after: Jiangsu Fugang Biotechnology Co. Ltd. Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Patentee before: Qingdao Huaren Technology Incubator Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180511 Address after: 225300 Longgang Road, Gaogang District, Taizhou, Jiangsu Province, No. 150 Patentee after: Jiangsu Gangcheng Chinese Medicine Health Co., Ltd. Address before: 225300 Jiangsu, Taizhou, Taizhou, Gao Gang Port Street north of the Far East Avenue Patentee before: Jiangsu Fugang Biotechnology Co. Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140917 Termination date: 20181231 |